BIORETEC OY - Asset Resilience Ratio
BIORETEC OY (0TN) has an Asset Resilience Ratio of 26.06% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See BIORETEC OY current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2025)
This chart shows how BIORETEC OY's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see BIORETEC OY (0TN) total assets.
Liquid Assets Composition Over Time
This chart breaks down BIORETEC OY's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read 0TN current and long-term liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €3.04 Million | 26.06% |
| Total Liquid Assets | €3.04 Million | 26.06% |
Asset Resilience Insights
- Very High Liquidity: BIORETEC OY maintains exceptional liquid asset reserves at 26.06% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
BIORETEC OY Industry Peers by Asset Resilience Ratio
Compare BIORETEC OY's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Medtronic plc
SA:MDTC34 |
Medical Devices | 7.82% |
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Theradiag SA
PA:ALTHE |
Medical Devices | 15.59% |
|
Biosynex
PA:ALBIO |
Medical Devices | 3.35% |
Annual Asset Resilience Ratio for BIORETEC OY (2021–2025)
The table below shows the annual Asset Resilience Ratio data for BIORETEC OY.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 26.06% | €3.04 Million ≈ $3.56 Million |
€11.68 Million ≈ $13.65 Million |
+4.68pp |
| 2024-12-31 | 21.37% | €2.45 Million ≈ $2.87 Million |
€11.47 Million ≈ $13.42 Million |
-7.96pp |
| 2023-12-31 | 29.33% | €3.13 Million ≈ $3.65 Million |
€10.66 Million ≈ $12.46 Million |
+0.22pp |
| 2022-12-31 | 29.11% | €1.02 Million ≈ $1.19 Million |
€3.49 Million ≈ $4.08 Million |
-46.15pp |
| 2021-12-31 | 75.27% | €6.46 Million ≈ $7.55 Million |
€8.58 Million ≈ $10.03 Million |
-- |
About BIORETEC OY
Bioretec Oy, a medical device company, develops, manufactures, and markets bioresorbable orthopedic implants for the repair of bone and soft tissue injuries in children and adults worldwide. The company offers Activa IM-Nail, a bioabsorbable option for pediatric forearm intramedullary nailing; ActivaNail, an implant that is be used in upper or lower limbs to ensure successful bone regeneration; A… Read more